• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.

作者信息

Pujari Sanjay N, Makane Abhimanyu, Lodha Abhijit, Bele Vivek, Joshi Kedar

机构信息

Institute of Infectious Diseases, Pune, India.

出版信息

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e82-4. doi: 10.1097/QAI.0b013e3182a6104a.

DOI:10.1097/QAI.0b013e3182a6104a
PMID:24442229
Abstract
摘要

相似文献

1
Short-term effectiveness and safety of third-line antiretroviral regimens among patients in Western India.印度西部患者中三线抗逆转录病毒疗法的短期有效性和安全性
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e82-4. doi: 10.1097/QAI.0b013e3182a6104a.
2
Antiretroviral reduction: is it time to rethink the unthinkable?抗逆转录病毒治疗减量：是时候重新思考不可想象之事了吗？
AIDS. 2014 Apr 24;28(7):943-7. doi: 10.1097/QAD.0000000000000187.
3
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).开始使用依非韦伦、洛匹那韦-利托那韦或阿扎那韦-利托那韦联合替诺福韦/恩曲他滨的初治严重免疫抑制的HIV-1感染患者的免疫重建：48周最终结果（Advanz-3试验）
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):206-15. doi: 10.1097/QAI.0000000000000567.
4
Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.采用基于触发机制的设计研究孕期抗逆转录病毒暴露与暴露于HIV但未感染的婴幼儿不良结局的关系。
AIDS. 2016 Jan 2;30(1):133-44. doi: 10.1097/QAD.0000000000000916.
5
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa.三种二线抗逆转录病毒治疗方案在非洲HIV感染患者中的疗效与安全性
AIDS. 2015 Jul 31;29(12):1473-81. doi: 10.1097/QAD.0000000000000709.
6
Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria.抗逆转录病毒疗法相关的药物不良反应及其对病毒学失败的影响——尼日利亚的一项回顾性队列研究
Curr HIV Res. 2018;16(6):436-446. doi: 10.2174/1389450120666190214144609.
7
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).每日一次利托那韦增强的阿扎那韦或达芦那韦联合双核苷（酸）类似物骨干药物用于初治的严重免疫抑制的HIV-1感染患者的抗逆转录病毒联合治疗（cART）的疗效和安全性：一项48周、非对照、随机、多中心试验（IMEA 040 DATA试验）
J Antimicrob Chemother. 2016 Aug;71(8):2252-61. doi: 10.1093/jac/dkw103. Epub 2016 Apr 10.
8
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.南非二线抗逆转录病毒疗法启动患者的药物不良反应。
Drug Saf. 2018 Dec;41(12):1343-1353. doi: 10.1007/s40264-018-0698-3.
9
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.在临床实践中，使用增效后的蛋白酶抑制剂进行单药治疗作为一种 ART 简化策略。
J Antimicrob Chemother. 2015 Apr;70(4):1124-9. doi: 10.1093/jac/dku509. Epub 2014 Dec 18.
10
Adverse Drug Reactions in HIV/AIDS Patients at a Tertiary Care Hospital in Penang, Malaysia.马来西亚槟城一家三级护理医院中艾滋病病毒/艾滋病患者的药物不良反应
Jpn J Infect Dis. 2016;69(1):56-9. doi: 10.7883/yoken.JJID.2014.246. Epub 2015 Jun 12.

引用本文的文献

1
Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.印度孟买疑似二线抗逆转录病毒治疗失败病例转为三线治疗或继续二线治疗的基因分型和结局。
PLoS One. 2019 Nov 21;14(11):e0225631. doi: 10.1371/journal.pone.0225631. eCollection 2019.
2
Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.预防人类免疫缺陷病毒耐药性的区域挑战
J Infect Dis. 2017 Dec 1;216(suppl_9):S816-S819. doi: 10.1093/infdis/jix408.
3
Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India.
印度孟买二线治疗失败及三线抗逆转录病毒治疗的首次经验
Glob Health Action. 2014 Jul 30;7:24861. doi: 10.3402/gha.v7.24861. eCollection 2014.